Stockreport

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

Ocugen, Inc.  (OCGN) 
PDF MALVERN, Pa., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and co [Read more]